Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure
Clinical trial NCT06336954 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06336954
- Sponsor
- Second Affiliated Hospital of Xi'an Jiaotong University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-30
- Primary completion
- 2024-07-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.